What is Limbrel?
Limbrel (generically known as flavocoxid) is a prescription dietary supplement. It is promoted for treatment of moderate to severe symptoms of osteoarthritis. Limbrel is marketed by Primus Pharmaceuticals, Inc.
FDA recommends patients to stop using Limbrel immediately
On December 18, 2017, the US Food and Drug Administration (FDA) sent a notice to Primus Pharmaceuticals to “cease distribution and immediately initiate a recall of all lots of Limbrel 250 mg capsules, Limbrel250 capsules, Limbrel 500 mg capsules, and Limbrel500 capsules.
The notice further stated that the FDA has determined that these Limbrel products are unapproved new drugs and represent a serious health hazard. The FDA received 194 adverse event reports associated with Limbrel products between January 1, 2007 and November 9, 2017.
Read the letter the FDA sent to Primus Pharmaceuticals
What are the side effects of Limbrel?
According to the FDA, Limbrel has been closely linked to:
- Drug-induced liver injury (DILI)
- Hypersensitivity pneumonitis (HP)
The severity of these conditions range from mild to life-threatening. These conditions may go unnoticed by the patient until symptoms develop that require hospitalization, such as respiratory failure.
The FDA anticipates classifying this recall as a Class I recall because it represents a serious health hazard which may be life-threatening.
If you or a loved one has been affected by Limbrel, an experienced attorney can help you navigate the legal system and seek justice.
At The Hannon Law Firm, LLC, we have 22 years of experience Seeking Justice with Compassion (SM). Our legal team is sensitive to the needs of individuals with personal injuries and knows how traumatic injuries can impact your entire family.
You can call our office at 303-861-8800 or contact us through the form below.